미국 약사

10/20/2026

https://www.reuters.com/business/healthcare-pharmaceuticals/pharma-sector-doubles-down-ai-amid-hopes-slashing-costs-timelines-2026-10-14/

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development, betting on new modeling tools and automated labs to improve efficiency across their pipelines.

10/20/2026

https://www.reuters.com/legal/transactional/chinas-hansoh-pharma-strikes-drug-deal-with-roche-worth-over-15-billion-2026-10-19/

China's Hansoh Pharmaceutical said on ‌Monday it has entered into a partnership and licensing deal with Roche potentially worth more than $15 billion that covers a portfolio of antibody-drug conjugate programs.

10/20/2026

https://www.reuters.com/legal/litigation/germanys-merck-buys-silence-therapeutics-13-billion-2026-10-19/

German drugmaker Merck KGaA said on Monday it would acquire UK-based Silence Therapeutics in ​an all-cash deal for about $1.3 billion, bolstering its pipeline of precision medicines and ‌adding RNA-targeting drug technology.

10/20/2026

https://www.msn.com/en-us/money/general/astrazeneca-partners-with-oracle-for-ai-driven-clinical-trials/ar-AA2fDEGX

10/20/2026

https://www.straitstimes.com/world/united-states/as-weight-loss-drug-users-turn-to-dietary-supplements-doctors-and-regulators-raise-flags?ref=latest-headlines

GLP-1 drug users drive supplement sales as doctors and regulators raise concerns over marketing and oversight. Read more at straitstimes.com.

10/19/2026

https://www.msn.com/en-us/news/other/roche-to-unveil-lung-breast-cancer-data-at-esmo-2026/ar-AA2fy53Y

10/19/2026

https://www.reuters.com/legal/litigation/roche-moves-future-germany-investments-on-hold-2026-10-19/

10/19/2026

https://www.msn.com/en-us/news/other/cherry-or-tabasco-perfumers-test-weight-loss-drug-users-appetite-for-food-inspired-scents/ar-AA2fy5Uk

10/17/2026

https://www.msn.com/en-us/news/other/explainer-how-does-the-us-count-measles-deaths/ar-AA2eft3d

10/17/2026

https://www.reuters.com/legal/litigation/eli-lillys-weight-loss-pill-wins-backing-europe-2026-10-16/

The ‌European Medicines Agency's committee on Friday recommended approval of Eli Lilly's weight-loss pill Foundayo, the second oral obesity drug to win the agency's backing after Novo Nordisk's Wegovy pill.